What DSO Buyers Actually Look For Before Making an Offer

Most dentists approach a DSO conversation from the wrong direction. They lead with what they want from the deal — the multiple, the equity rollover, the clinical autonomy provisions. The buyers who pay the most are the ones who understand what the DSO wants — and have built their practice accordingly.

I have been on both sides of this conversation. As the founder of Afinia Dental Group, I sold to a buyer who had evaluated hundreds of practices. What I learned from that process — and from the years of preparation that preceded it — fundamentally changed how I think about practice valuation.

The Four Things Every DSO Buyer Is Actually Evaluating

1. EBITDA Quality, Not Just EBITDA

Every dentist who has had a preliminary DSO conversation knows that the deal is driven by a multiple of EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization). What fewer dentists understand is that buyers distinguish sharply between high-quality EBITDA and low-quality EBITDA.

High-quality EBITDA is recurring, predictable, and not dependent on the owner's clinical production. Low-quality EBITDA is lumpy, heavily owner-dependent, or driven by one-time factors like a large insurance renegotiation or a temporary reduction in staffing costs.

Buyers will apply a higher multiple to high-quality EBITDA and a lower multiple — or no offer at all — to low-quality EBITDA. The difference between the two can be worth hundreds of thousands of dollars in a transaction.

2. Owner Dependency

This is the single most common deal-killer I see in dental practice sales. When a buyer's due diligence reveals that the practice's production is 60%, 70%, or 80% driven by the owner-dentist, the risk profile of the acquisition changes dramatically.

Buyers are not purchasing a job for themselves. They are purchasing a business — a system that generates revenue independent of any single individual. A practice where the owner has successfully transitioned production to associates, built a strong hygiene program, and developed a leadership team that can operate without daily owner involvement is worth significantly more than a practice of equal revenue where the owner is the practice.

3. Systems and Documentation

DSO buyers are, at their core, systems integrators. Their competitive advantage is the ability to take well-run practices and plug them into a larger operational infrastructure. Practices that already have documented systems — for scheduling, treatment presentation, billing, HR, and clinical protocols — integrate faster and at lower cost.

Practices without documentation require the buyer to build systems from scratch, which is expensive and time-consuming. That cost comes out of the purchase price.

4. Culture and Team Stability

High turnover is a red flag in any due diligence process. A practice where the front desk turns over every 18 months, where hygienists come and go, and where the clinical team lacks cohesion signals to a buyer that something is wrong beneath the surface — even if the financials look clean.

The practices that command the highest multiples are the ones where the team is stable, engaged, and capable of operating effectively without the owner in the room. That kind of team does not happen by accident. It is built through intentional leadership, clear systems, and a culture of accountability.

What This Means for You

If you are thinking about a DSO exit in the next three to five years, the time to start preparing is now. Not when you receive your first letter of interest. Not when you hire a broker. Now.

The practices that receive the best offers are the ones that have spent 18 to 36 months systematically reducing owner dependency, documenting their operations, and building a team that can run the practice without them. That preparation is not just good business practice — it is the difference between a good deal and a great one.